The COLON Study: Colorectal Cancer Cohort
Study Details
Study Description
Brief Summary
The main aim of this observational, prospective cohort study is to assess associations of diet and other lifestyle factors with colorectal cancer recurrence, survival and quality of life.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The COLON study is a multi-centre prospective cohort study among incident colorectal cancer patients recruited from 12 hospitals in the Netherlands. Patients with colorectal cancer are invited upon diagnosis. Upon recruitment, after 6 months, 2 years and 5 years, patients fill out food-frequency questionnaires; questionnaires about dietary supplement use, physical activity, weight, height, and quality of life; and donate blood samples. Diagnostic CT-scans are collected to assess cross-sectional areas of skeletal muscle, subcutaneous fat, visceral fat and intermuscular fat, and to assess muscle attenuation. Blood samples are biobanked to facilitate future analyse of biomarkers, nutrients, DNA etc. Analysis of serum 25-hydroxy vitamin D levels, B-vitamins and metabolomic profiles are scheduled. A subgroup of patients with colon cancer is asked to provide faecal samples before and at several time points after colon resection to study changes in gut microbiota during treatment. For all patients, information on vital status is retrieved by linkage with national registries. Information on clinical characteristics, including treatment-related toxicity and co-morbidity data, is gathered from linkage with the Netherlands Cancer Registry and with hospital databases or medical records. Hazard ratios will be calculated for dietary and lifestyle factors at diagnosis in relation to recurrence and survival. Repeated measures analyses will be performed to assess changes over time in dietary and other factors in relation to recurrence and survival.
The aim is to recruit at least 2000 patients with available data and blood samples.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Colorectal cancer patients
|
Other: No intervention: observational study
|
Outcome Measures
Primary Outcome Measures
- Survival [An average follow-up of at least 5 years]
Overall survival
- Cancer recurrence [An average follow-up of at least 5 years]
Cancer recurrence
- Quality of life (EORTC QLQ-C30) [An average follow-up of at least 5 years]
Quality of life
Secondary Outcome Measures
- Chemotherapy-induced toxicity (QLQ-CIPN20) [12 months after diagnosis]
Chemotherapy-induced peripheral neuropathy
- Microbiota composition based on 16S rRNA profiling [At diagnosis and 6, 12 and 35 weeks after resection]
Stool samples
- Co-morbidities [An average follow-up of at least 5 years]
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients newly diagnosed with colorectal cancer in one of the participating hospitals
Exclusion Criteria:
-
Non-Dutch speaking
-
A history of colorectal cancer or (partial) bowel resection
-
Chronic inflammatory bowel disease
-
Hereditary colorectal cancer syndromes (Lynch syndrome, FAP, Peutz-Jegher)
-
Dementia or another mental condition that makes it impossible to fill out questionnaires
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Ziekenhuisgroep Twente | Almelo | Netherlands | ||
2 | Gelre Hospital | Apeldoorn | Netherlands | ||
3 | Rijnstate Hospital | Arnhem | Netherlands | ||
4 | Slingeland Hospital | Doetinchem | Netherlands | ||
5 | Hospital Gelderse Vallei | Ede | Netherlands | ||
6 | Admiraal De Ruyter Hospital | Goes/Vlissingen | Netherlands | ||
7 | Martini Hospital | Groningen | Netherlands | ||
8 | Canisius Wilhelmina Hospital | Nijmegen | Netherlands | ||
9 | Radboudumc | Nijmegen | Netherlands | ||
10 | Bernhoven Hospital | Oss | Netherlands | ||
11 | Isala Klinieken | Zwolle | Netherlands |
Sponsors and Collaborators
- Wageningen University
- Dutch Cancer Society
- Wereld Kanker Onderzoek Fonds
- Funding: World Cancer Research Fund International
- Funding: ERA-NET on Translational Cancer Research (TRANSCAN)
Investigators
- Principal Investigator: Ellen Kampman, PhD, Wageningen University
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
- van Zutphen M, Winkels RM, van Duijnhoven FJ, van Harten-Gerritsen SA, Kok DE, van Duijvendijk P, van Halteren HK, Hansson BM, Kruyt FM, Bilgen EJ, de Wilt JH, Dronkers JJ, Kampman E. An increase in physical activity after colorectal cancer surgery is associated with improved recovery of physical functioning: a prospective cohort study. BMC Cancer. 2017 Jan 25;17(1):74. doi: 10.1186/s12885-017-3066-2.
- Winkels RM, Heine-Bröring RC, van Zutphen M, van Harten-Gerritsen S, Kok DE, van Duijnhoven FJ, Kampman E. The COLON study: Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of life. BMC Cancer. 2014 May 27;14:374. doi: 10.1186/1471-2407-14-374.
- NL30446.091.09
- CMO number 2009/349